These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 19270623)

  • 1. Unintentional rapid opioid detoxification: case report.
    Singh SM; Sharma B
    Psychiatr Danub; 2009 Mar; 21(1):65-7. PubMed ID: 19270623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency management of inadvertent accelerated opiate withdrawal in dependent opiate users.
    Lubman D; Koutsogiannis Z; Kronborg I
    Drug Alcohol Rev; 2003 Dec; 22(4):433-6. PubMed ID: 14660133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
    Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
    J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected delirium during Rapid Opioid Detoxification (ROD).
    Golden SA; Sakhrani DL
    J Addict Dis; 2004; 23(1):65-75. PubMed ID: 15077841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Withdrawal syndrome caused by naltrexone in opioid abusers.
    Hassanian-Moghaddam H; Afzali S; Pooya A
    Hum Exp Toxicol; 2014 Jun; 33(6):561-7. PubMed ID: 23690227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonist treatment of opioid withdrawal translational low dose approach.
    Mannelli P; Gottheil E; Van Bockstaele EJ
    J Addict Dis; 2006; 25(2):1-8. PubMed ID: 16785213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges to antagonist blockade during sustained-release naltrexone treatment.
    Kunøe N; Lobmaier P; Vederhus JK; Hjerkinn B; Gossop M; Hegstad S; Kristensen Ø; Waal H
    Addiction; 2010 Sep; 105(9):1633-9. PubMed ID: 20707781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does naltrexone affect craving in abstinent opioid-dependent patients?
    Dijkstra BA; De Jong CA; Bluschke SM; Krabbe PF; van der Staak CP
    Addict Biol; 2007 Jun; 12(2):176-82. PubMed ID: 17508990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone plus benzodiazepine aids abstinence in opioid-dependent patients.
    Stella L; D'Ambra C; Mazzeo F; Capuano A; Del Franco F; Avolio A; Ambrosino F
    Life Sci; 2005 Oct; 77(21):2717-22. PubMed ID: 15979652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unintentional rapid opioid detoxification.
    Quigley MA; Boyce SH
    Emerg Med J; 2001 Nov; 18(6):494-5. PubMed ID: 11696513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone-assisted rapid methadone discontinuation: a pilot study.
    Camarasa X; Khazaal Y; Besson J; Zullino DF
    Eur Addict Res; 2007; 13(1):20-4. PubMed ID: 17172775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid-dependent error processing.
    Fellows-Smith J
    J Opioid Manag; 2011; 7(6):443-9. PubMed ID: 22320026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The place of detoxification in treatment of opioid dependence.
    Gowing LR; Ali RL
    Curr Opin Psychiatry; 2006 May; 19(3):266-70. PubMed ID: 16612211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The opioids: abuse liability and treatments for dependence.
    Ternes JW; O'Brien CP
    Adv Alcohol Subst Abuse; 1990; 9(1-2):27-45. PubMed ID: 2198785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precipitated withdrawal during maintenance opioid blockade with extended release naltrexone.
    Fishman M
    Addiction; 2008 Aug; 103(8):1399-401. PubMed ID: 18855831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of symptom withdrawal severity in a 24-hour period after the anesthesia-assisted rapid opiate detoxification procedure.
    Teplin D; Raz B; Daiter J; Varenbut M; Zachos CT; Whang P; Herman S; Chaudry S; Yung M
    Am J Drug Alcohol Abuse; 2005; 31(2):327-35. PubMed ID: 15912719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complications of accelerated opioid detoxification].
    Zemtsovskiĭ MIu; Kipriianov VS; Tros'ko OU; Brazhnikov AV; Strashnov VI
    Anesteziol Reanimatol; 2005; (3):11-5. PubMed ID: 16076037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome and six month follow up of patients after Ultra Rapid Opiate Detoxification (UROD).
    Albanese AP; Gevirtz C; Oppenheim B; Field JM; Abels I; Eustace JC
    J Addict Dis; 2000; 19(2):11-28. PubMed ID: 10809517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming opioid blockade from depot naltrexone (Prodetoxon).
    Kruptisky EM; Burakov AM; Tsoy MV; Egorova VY; Slavina TY; Grinenko AY; Zvartau EE; Woody GE
    Addiction; 2007 Jul; 102(7):1164-5. PubMed ID: 17498182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First case of stress cardiomyopathy as a result of methadone withdrawal secondary to drug-drug interaction.
    Lemesle F; Lemesle F; Nicola W; Pierre Jonville-Béra A
    Am J Emerg Med; 2010 Mar; 28(3):387.e5-6. PubMed ID: 20223408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.